BioPharma Credit PLC declare an interim dividend in respect of the financial period ended 30 September 2023 of $0.0375 per ordinary share, payable on 5 January 2024 to ordinary shareholders on the register as at 8 December 2023. The ex-dividend date will be 7 December 2023. The $0.0375 dividend comprises an ordinary dividend of $0.0175 and a special dividend of $0.0200The Company is currently paying and continues to target a 7 cent annual dividend per ordinary share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.88 USD | +0.23% | +0.23% | +4.76% |
02/05 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
02/05 | BioPharma Credit agrees USD400 million loan for oncology firm Novacure | AN |
1st Jan change | Capi. | |
---|---|---|
+4.76% | 1.07B | |
+5.54% | 12.82B | |
+12.07% | 9.62B | |
+7.22% | 5.64B | |
+0.05% | 5.56B | |
+6.07% | 5.23B | |
+18.19% | 4.63B | |
+17.74% | 4.53B | |
+2.73% | 4.07B | |
+5.29% | 3.94B |
- Stock Market
- Equities
- BPCP Stock
- News BioPharma Credit PLC
- BioPharma Credit PLC Declares Interim Dividend in Respect of the Financial Period Ended 30 September 2023, Payable on 5 January 2024